XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Cash flows from operating activities    
Net income (loss) $ (203,497) $ (172,580)
Adjustments to reconcile net income (loss) (used in) operating activities:    
Depreciation 4,151 4,156
Stock-based compensation 2,491 0
Accretion for debt discounts, warrants and issuance cost 0 18,621
Changes in current assets and liabilities    
Accounts receivable 171 14,106
Inventory 15,267 (9,182)
Prepaid expenses and other assets (114,276) 1,327
Accounts payable (461,415) 30,949
Accrued liabilities (39,634) (74,140)
Accrued interest 27,412 21,730
Accrued payroll liabilities (469) (3,621)
Net cash used in operating activities (769,799) (168,634)
Cash flows from investing activities    
Cash received in reverse merger 256,255 0
Investment in unconsolidated investee (35,000) 0
Purchase of fixed assets 0 (12,775)
Net cash provided by (used in) investing activities 221,255 (12,775)
Cash flows from financing activities    
Issuance of convertible notes payable 0 190,000
Issuance of common stock Series C convertible preferred stock in connection with investment upon merger, net of $20,000 in fees 3,980,000 0
Net cash provided by financing activities 3,980,000 190,000
Net increase in cash 3,431,456 8,591
Cash at beginning of period 35,289 15,887
Cash at end of period 3,466,745 24,478
Non-cash investing and financing activities:    
Assets acquired and (liabilities assumed) in reverse merger cash 256,255 0
Assets acquired and (liabilities assumed) in reverse merger accounts payable (860,812) 0
Net liabilities assumed (604,557) 0
Investment made in unconsolidated investee $ 1,000,000 $ 0